{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T22:02:25Z","timestamp":1793397745606,"version":"4.5.0"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,3]],"date-time":"2023-03-03T00:00:00Z","timestamp":1677801600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:p>\n                    Immune complex (IC) vasculitides present inflammations of vessel walls associated with perivascular deposition of immunoglobulins (Igs), mostly ICs. They encompass systemic and skin-limited variants of IgA vasculitis (IgAV), cryoglobulinemic vasculitis (CV), rheumatoid, lupus, and hypocomplementemic vasculitides, serum sickness cutaneous IgM\/IgG (non-IgA) vasculitis, and recurrent macular (hypergammaglobulinemic or exertion-induced) vasculitis. Serum sickness and CV fulfill the criteria of a type III hypersensitivity immune reaction as large lattices of the IC precipitate at vessel walls and activate polymorphonuclear neutrophils (PMNs). Immunoglobulin-A vasculitis differs with regard to the causes of perivascular deposition of ICs since here many IgA1 molecules are hypoglycosylated (Gd-IgA1), which appears to facilitate their perivascular deposition in skin and mesangium (via e.g. CD71). The reasons for increased generation of immunoglobulins or formation of IC and their perivascular deposition in either skin or systemic organs are different and not fully explored. A common denominator of OC vasculitides is the activation of PMNs near the vessel wall\n                    <jats:italic>via<\/jats:italic>\n                    Fcy or Fc\u03b1 receptors. Acute episodes of IgAV additionally require PMNs to become preactivated by IgA1 or by IC already in circulation. This intravascular priming results in increased adherence and subsequently vessel-destructive NETosis when they encounter IgA deposited at the vessel walls. Binding of IgA1 to PMNs in blood stream is associated with increased serum levels of hypogalactosidated IgA1. The characteristic clinical picture of IgAV (and also of so-called IgG\/IgM vasculitis) comprises palpable or retiform purpura with a clear predilection for lower legs, probably due to stasis-related reduction in blood velocity, while in other IC vasculitides, additional factors influence the sites of vasculitides. Our knowledge of distinct forms and different pathophysiological pathways of IC vasculitides may lead to in efficacious or targeted therapies. Antibodies to complement components or intestinal budesonide for IgAV are promising agents (the latter suppresses the pathophysiologically related IgA nephropathy by reducing the generation of mucosal IgA.\n                  <\/jats:p>","DOI":"10.3389\/fmed.2023.1103065","type":"journal-article","created":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T23:37:58Z","timestamp":1677800278000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Pathophysiology and clinical manifestations of immune complex vasculitides"],"prefix":"10.3389","volume":"10","author":[{"given":"Cord","family":"Sunderk\u00f6tter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Golle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evang\u00e9line","family":"Pillebout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Michl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/art.40375","article-title":"Nomenclature of cutaneous vasculitis: dermatologic addendum to the 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"70","author":"Sunderkotter","year":"2018","journal-title":"Arthritis Rheumatol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.jdcr.2019.01.013","article-title":"Evidence for immunoglobulin-mediated vasculitis caused by monoclonal gammopathy in monoclonal gammopathy of unclear significance prompting oncologic treatment","volume":"5","author":"Drerup","year":"2019","journal-title":"JAAD Case Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum."},{"key":"B4","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/0923-2494(96)87183-5","article-title":"Complement and immune complexes","volume":"147","author":"Schifferli","year":"1996","journal-title":"Res Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1056\/NEJM198608213150805","article-title":"The role of complement and its receptor in the elimination of immune complexes","volume":"315","author":"Schifferli","year":"1986","journal-title":"N Engl J Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.autrev.2017.10.009","article-title":"New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schonlein purpura)","volume":"16","author":"Heineke","year":"2017","journal-title":"Autoimmun Rev."},{"key":"B7","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s00281-021-00874-9","article-title":"IgA vasculitis","volume":"43","author":"Pillebout","year":"2021","journal-title":"Semin Immunopathol."},{"key":"B8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1001\/archderm.1989.01670130055006","article-title":"A cutaneous sign of IgA-associated small dermal vessel leukocytoclastic vasculitis in adults (Henoch-Schonlein purpura)","volume":"125","author":"Piette","year":"1989","journal-title":"Arch Dermatol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jaad.2008.11.913","article-title":"Scalp necrosis in giant cell arteritis: case report and review of the relevance of this cutaneous sign of large-vessel vasculitis","volume":"61","author":"Tsianakas","year":"2009","journal-title":"J Am Acad Dermatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1093\/rheumatology\/kez061.023","article-title":"Galactose-deficient IgA1 (GD-IgA1) in skin and serum from patients with skin-limited and systemic IgA vasculitis","volume":"81","author":"Neufeld","year":"2019","journal-title":"J Am Acad Dermatol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1046\/j.1523-1755.2001.00565.x","article-title":"What is the difference between IgA nephropathy and Henoch-Schonlein purpura nephritis?","volume":"59","author":"Davin","year":"2001","journal-title":"Kidney Int."},{"key":"B12","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00467-021-04950-y","article-title":"IgA vasculitis with nephritis: update of pathogenesis with clinical implications","volume":"37","author":"Hastings","year":"2022","journal-title":"Pediatr Nephrol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"e0232194","DOI":"10.1371\/journal.pone.0232194","article-title":"A cross-sectional analysis of clinicopathologic similarities and differences between Henoch-Schonlein purpura nephritis and IgA nephropathy","volume":"15","author":"Sugiyama","year":"2020","journal-title":"PLoS ONE."},{"key":"B14","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/S0140-6736(02)09835-5","article-title":"The adult kidney 24 years after childhood Henoch-Schonlein purpura: a retrospective cohort study","volume":"360","author":"Ronkainen","year":"2002","journal-title":"Lancet."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1097\/01.ASN.0000013883.99976.22","article-title":"Henoch-Schonlein purpura in adults: outcome and prognostic factors","volume":"13","author":"Pillebout","year":"2002","journal-title":"J Am Soc Nephrol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"921864","DOI":"10.3389\/fimmu.2022.921864","article-title":"IgA vasculitis update: epidemiology, pathogenesis, and biomarkers","volume":"13","author":"Xu","year":"2022","journal-title":"Front Immunol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.ekir.2019.08.015","article-title":"Autoantibodies specific for galactose-deficient IgA1 in IgA vasculitis with nephritis","volume":"4","author":"Suzuki","year":"2019","journal-title":"Kidney Int Rep."},{"key":"B18","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1038\/ki.2011.16","article-title":"Aberrant glycosylation of IgA1 Is inherited in both pediatric IgA nephropathy and Henoch-Schonlein purpura nephritis","volume":"80","author":"Kiryluk","year":"2011","journal-title":"Kidney Int."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1681\/ASN.2007091052","article-title":"Aberrant IgA1 glycosylation is inherited in familial and sporadic IgA nephropathy","volume":"19","author":"Gharavi","year":"2008","journal-title":"J Am Soc Nephrol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1007\/s00467-007-0623-y","article-title":"Serum levels of galactose-deficient IgA in children with IgA nephropathy and Henoch-Schonlein purpura","volume":"22","author":"Lau","year":"2007","journal-title":"Pediatr Nephrol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1093\/ndt\/gfx300","article-title":"Value of biomarkers for predicting immunoglobulin A vasculitis nephritis outcome in an adult prospective cohort","volume":"33","author":"Berthelot","year":"2017","journal-title":"Nephrol Dial Transplant."},{"key":"B22","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1093\/ndt\/gfz151","article-title":"Plasma galactose-deficient immunoglobulin A1 and loss of kidney function in patients with immunoglobulin A vasculitis nephritis","volume":"35","author":"Zhang","year":"2019","journal-title":"Nephrol Dial Transplant."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e0188718","DOI":"10.1371\/journal.pone.0188718","article-title":"Biomarkers of IgA vasculitis nephritis in children","volume":"12","author":"Pillebout","year":"2017","journal-title":"PLoS ONE."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1016\/S0140-6736(17)30550-0","article-title":"Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial","volume":"389","author":"Fellstrom","year":"2017","journal-title":"Lancet."},{"key":"B25","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.kint.2022.09.017","article-title":"Results from part A of the multi-center, double-blind, randomized, placebo-controlled nefigard trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy","volume":"103","author":"Barratt","year":"2022","journal-title":"Kidney Int."},{"key":"B26","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/00005792-199911000-00005","article-title":"Henoch-Schonlein purpura in children. Report of 100 patients and review of the literature","volume":"78","author":"Saulsbury","year":"1999","journal-title":"Medicine (Baltimore)."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1172\/JCI38468","article-title":"Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity","volume":"119","author":"Suzuki","year":"2009","journal-title":"J Clin Invest."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e0190967","DOI":"10.1371\/journal.pone.0190967","article-title":"Serum galactose-deficient-IgA1 and IgG autoantibodies correlate in patients with IgA nephropathy","volume":"13","author":"Placzek","year":"2018","journal-title":"PLoS ONE."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.1093\/ndt\/gfr149","article-title":"Immune complexes in acute adult-onset Henoch-Schonlein nephritis","volume":"26","author":"Hilhorst","year":"2011","journal-title":"Nephrol Dial Transplant."},{"key":"B30","first-page":"230","article-title":"Circulating Immune complexes containing IgA, IgG and IgM in patients with primary IgA nephropathy and with Henoch-Schoenlein nephritis. Correlation with clinical and histologic signs of activity","volume":"18","author":"Coppo","year":"1982","journal-title":"Clin Nephrol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.4049\/jimmunol.2100924","article-title":"Systemic activation of neutrophils by immune complexes is critical to IgA vasculitis","volume":"209","author":"Mayer-Hain","year":"2022","journal-title":"J Immunol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.4049\/jimmunol.156.4.1549","article-title":"Dermal microvascular endothelial cells express CD32 receptors in vivo and in vitro","volume":"156","author":"Groger","year":"1996","journal-title":"J Immunol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1134\/S1990747819030140","article-title":"Markers of endothelial cells in normal and pathological conditions","volume":"14","author":"Goncharov","year":"2020","journal-title":"Biochem (Mosc) Suppl Ser A Membr Cell Biol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1600-0625.2008.00791.x","article-title":"Vasculitis of small blood vessels\u2013some riddles about IgA and about the complexity of transmigration","volume":"18","author":"Sunderkotter","year":"2009","journal-title":"Exp Dermatol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1681\/ASN.2018111156","article-title":"Glomerular immunodeposits of patients with IgA nephropathy are enriched for IgG autoantibodies specific for galactose-deficient IgA1","volume":"30","author":"Rizk","year":"2019","journal-title":"J Am Soc Nephrol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S1074-7613(00)80264-2","article-title":"Dominant role for mast cell Fc receptors in the arthus reaction","volume":"5","author":"Sylvestre","year":"1996","journal-title":"Immunity."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.4049\/jimmunol.107.6.1535","article-title":"The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles","volume":"107","author":"Henson","year":"1971","journal-title":"J Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.4049\/jimmunol.1400478","article-title":"Immobilized immune complexes induce neutrophil extracellular trap release by human neutrophil granulocytes via Fc\u03b3RIIIB and Mac-1","volume":"193","author":"Behnen","year":"2014","journal-title":"J Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"4421","DOI":"10.1182\/blood-2011-12-401133","article-title":"Endocytosis of soluble immune complexes leads to their clearance by Fc\u03b3RIIIB but induces neutrophil extracellular traps via Fc\u03b3RIIA in vivo","volume":"120","author":"Chen","year":"2012","journal-title":"Blood."},{"key":"B40","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.4049\/jimmunol.1300261","article-title":"IgA enhances NETosis and release of neutrophil extracellular traps by polymorphonuclear cells via Fc\u03b1 receptor I","volume":"192","author":"Aleyd","year":"2014","journal-title":"J Immunol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1002\/art.39153","article-title":"Neutrophil-related gene expression and low-density granulocytes associated with disease activity and response to treatment in antineutrophil cytoplasmic antibody-associated vasculitis","volume":"67","author":"Grayson","year":"2015","journal-title":"Arth Rheumatol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.kint.2018.03.010","article-title":"The net effect of ANCA on neutrophil extracellular trap formation","volume":"94","author":"Heeringa","year":"2018","journal-title":"Kidney Int."},{"key":"B43","doi-asserted-by":"publisher","first-page":"538","DOI":"10.4049\/jimmunol.1100450","article-title":"Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus","volume":"187","author":"Villanueva","year":"2011","journal-title":"J Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/JLB.3COVR0520-272R","article-title":"Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts","volume":"108","author":"Wang","year":"2020","journal-title":"J Leukoc Biol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/sj.jid.5700563","article-title":"Site of blood vessel damage and relevance of CD18 in a murine model of immune complex-mediated vasculitis","volume":"127","author":"Sindrilaru","year":"2007","journal-title":"J Invest Dermatol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1016\/j.febslet.2010.06.006","article-title":"Activated endothelial cells induce neutrophil extracellular traps and are susceptible to netosis-mediated cell death","volume":"584","author":"Gupta","year":"2010","journal-title":"FEBS Lett."},{"key":"B47","doi-asserted-by":"publisher","first-page":"e32366","DOI":"10.1371\/journal.pone.0032366","article-title":"Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones","volume":"7","author":"Saffarzadeh","year":"2012","journal-title":"PLoS ONE."},{"key":"B48","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1034\/j.1600-0625.2001.100602.x","article-title":"Different pathways leading to cutaneous leukocytoclastic vasculitis in mice","volume":"10","author":"Sunderkotter","year":"2001","journal-title":"Exp Dermatol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molimm.2021.09.010","article-title":"Is complement the main accomplice in IgA nephropathy? From initial observations to potential complement-targeted therapies","volume":"140","author":"Le Stang","year":"2021","journal-title":"Mol Immunol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.molimm.2022.01.011","article-title":"Lectin and alternative complement pathway activation in cutaneous manifestations of IgA-vasculitis: a new target for therapy?","volume":"143","author":"Damman","year":"2022","journal-title":"Mol Immunol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"F956","DOI":"10.1152\/ajprenal.00532.2014","article-title":"Berg BMvd, Lee DH, Boels MGS, Tiemeier GL, Avramut MC, et al. A microscopic view on the renal endothelial glycocalyx","volume":"308","author":"Dane","year":"2015","journal-title":"Am J Physiol Renal Physiol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jaad.2020.04.060","article-title":"Clinical and immunopathologic features of idiopathic cutaneous immunoglobulin M\/G vasculitis versus idiopathic skin-limited immunoglobulin a vasculitis","volume":"84","author":"Marzano","year":"2021","journal-title":"J Am Acad Dermatol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/1523-1747.ep12510321","article-title":"Demonstration of immune complexes in spontaneous and histamine-induced lesions and in normal skin of patients with leukocytoclastic angitis","volume":"64","author":"Braverman","year":"1975","journal-title":"J Invest Dermatol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1084\/jem.124.4.733","article-title":"Polymorphonuclear leukocytes in immunologic reactions. The destruction of vascular basement membrane in vivo and in vitro","volume":"124","author":"Cochrane","year":"1966","journal-title":"J Exp Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/00005792-197103000-00004","article-title":"Hypergammaglobulinemic Purpura. Studies on the unusual anti-globulins characteristic of the sera of these patients","volume":"50","author":"Capra","year":"1971","journal-title":"Medicine."},{"key":"B56","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/978-88-470-1705-4_25","article-title":"Cutaneous cryoglobulinemic vasculitis","volume-title":"HCV Infection and Cryoglobulinemia","author":"Linos","year":"2012"},{"key":"B57","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/S0140-6736(11)60242-0","article-title":"The cryoglobulinaemias","volume":"379","author":"Ramos-Casals","year":"2012","journal-title":"Lancet."},{"key":"B58","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/MD.0b013e318288925c","article-title":"The spectrum of type I cryoglobulinemia vasculitis: new insights based on 64 cases","volume":"92","author":"Terrier","year":"2013","journal-title":"Medicine."},{"key":"B59","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/j.1600-0560.2006.00594.x","article-title":"Generalized livedo reticularis associated with monoclonal cryoglobulinemia and multiple myeloma","volume":"34","author":"Requena","year":"2007","journal-title":"J Cutan Pathol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1136\/ard.55.3.190","article-title":"Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study","volume":"55","author":"Voskuyl","year":"1996","journal-title":"Ann Rheum Dis."},{"key":"B61","first-page":"449","article-title":"IgA containing immune complexes in rheumatoid vasculitis and in active rheumatoid disease","volume":"12","author":"Westedt","year":"1985","journal-title":"J Rheumatol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1046\/j.1365-2133.2002.04933.x","article-title":"Clinical and histopathological spectrum of cutaneous vasculitis in rheumatoid arthritis","volume":"147","author":"Chen","year":"2002","journal-title":"Br J Dermatol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3109\/03009742.2014.923931","article-title":"Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sjogren's syndrome: results of a large multicentre study","volume":"44","author":"Quartuccio","year":"2015","journal-title":"Scand J Rheumatol."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1103065\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,2]],"date-time":"2023-03-02T23:38:02Z","timestamp":1677800282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1103065\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,3]]},"references-count":63,"alternative-id":["10.3389\/fmed.2023.1103065"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1103065","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,3]]},"article-number":"1103065"}}